Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 5/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6988257 | 0.84 | CHRM1 (0.59) | CHRM1 | |
| SCHEMBL6987593 | 0.83 | CHRM1 (0.39) | CHRM1 | |
| SCHEMBL6980912 | 0.83 | CHRM1 (0.39) | CHRM1 | |
| Hydrochloric Acid SCHEMBL6981044 | 0.82 | CHRM1 (0.38) | CHRM1 | |
| SCHEMBL6980919 | 0.82 | CHRM1 (0.48) | CHRM1 | |
| SCHEMBL6982103 | 0.80 | CHRM1 (0.38) | CHRM1 | |
| Hydrochloric Acid SCHEMBL6987410 | 0.79 | CHRM1 (0.37) | CHRM1 | |
| SCHEMBL6989372 | 0.78 | CHRM1 (0.38) | CHRM1 | |
| SCHEMBL6985817 | 0.78 | CHRM1 (0.35) | CHRM1 | |
| SCHEMBL7885720 | 0.78 | CHRM1 (0.44) | CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1189902-B1 | 7-OXO-2-AZABICYCLO[2.2.1]HEPTANES AS SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST | LILLY CO ELI (US) | 2003-08-27 | — | — | EP | claimed |
| US-6559171-B1 | Muscarinic receptor modulators 7-oxo-2-azabicyclo(2.2.1)heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, | ELI LILLY AND COMPANY | 2003-05-06 | — | — | US | claimed |
| EP-1189902-B1 | 7-OXO-2-AZABICYCLO[2.2.1]HEPTANES AS SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST | LILLY CO ELI (US) | 2003-08-27 | — | — | EP | disclosed |
| US-6559171-B1 | Muscarinic receptor modulators 7-oxo-2-azabicyclo(2.2.1)heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, | ELI LILLY AND COMPANY | 2003-05-06 | — | — | US | disclosed |